Updated March 1, 2026
CarniSema is Nimbus's proprietary compounded medication combining semaglutide and L-Carnitine.
Semaglutide is a GLP-1 receptor agonist — the active ingredient in brand-name Ozempic® (diabetes) and Wegovy® (weight loss). It works by:
L-Carnitine supports fat metabolism by helping transport fatty acids into cells to be burned for energy, complementing the appetite-reducing effects of semaglutide.
Doses are titrated gradually to minimize side effects. Your provider sets your specific protocol based on your health history and labs.
Still have a question?
Ask Nimy, our AI assistant.